A Prospective, Randomized, Double-Blind, Sham- Controlled, Multi-Center Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects with Type 2 Diabetes on Insulin therapy
Clinical Trial Grant
Administered By
Medicine, Endocrinology, Metabolism, and Nutrition
Awarded By
Fractyl Laboratories, Inc.
Start Date
January 3, 2022
End Date
January 2, 2027
Administered By
Medicine, Endocrinology, Metabolism, and Nutrition
Awarded By
Fractyl Laboratories, Inc.
Start Date
January 3, 2022
End Date
January 2, 2027